Spermatogenesis and oogenesis specific basic helix-loop-helix 2 (SOHLH2)

Spermatogenesis and oogenesis specific basic helix-loop-helix 2 (SOHLH2) is a germline-specific transcription factor that serves as a master regulator of early gametogenesis. In both males and females, it is essential for the transition of germline stem cells into differentiating gametes by modulating the expression of key developmental genes like KIT, SOX3, and GFRA1. Clinical research has firmly linked SOHLH2 dysfunction to reproductive pathologies, specifically non-obstructive azoospermia and primary ovarian insufficiency (premature ovarian failure), where genetic variants disrupt normal follicle and sperm development [1, 2, 9]. In addition to its role in fertility, SOHLH2 has been identified as a significant tumor suppressor in various malignancies, including epithelial ovarian cancer and breast cancer. Its downregulation, often via promoter hypermethylation, leads to increased cellular proliferation and metastasis through the activation of oncogenic pathways such as Wnt/beta-catenin and HIF1-alpha [2, 11]. While there are currently no approved drugs that directly target SOHLH2, it is a prominent subject of investigation for diagnostic screening in reproductive medicine and as a potential candidate for epigenetic or gene therapies aimed at restoring its tumor-suppressive functions in oncology.

Other names

Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2TEB1bHLHe81SPATA28Spermatogenesis associated 28SOHL2

SOHLH2 acts as a transcriptional regulator by forming homodimers or heterodimers with SOHLH1 to bind specific DNA sequences (E-boxes and GC-boxes), thereby controlling the expression of genes essential for germ cell differentiation, such as KIT and SOX3, while suppressing stem cell maintenance genes like GFRA1 and RET [1, 5, 8].